These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30384269)

  • 61. Assessing efficacy of combined riboflavin and UV-A light (365 nm) treatment of Acanthamoeba trophozoites.
    Kashiwabuchi RT; Carvalho FR; Khan YA; de Freitas D; Foronda AS; Hirai FE; Campos MS; McDonnell PJ
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9333-8. PubMed ID: 22058341
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of three different methods to establish animal models of Acanthamoeba keratitis.
    Ren M; Wu X
    Yonsei Med J; 2010 Jan; 51(1):121-7. PubMed ID: 20046525
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The pathophysiology of Acanthamoeba keratitis.
    Clarke DW; Niederkorn JY
    Trends Parasitol; 2006 Apr; 22(4):175-80. PubMed ID: 16500148
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impaired innate immunity of ocular surface is the key bridge between extended contact lens wearing and occurrence of Acanthamoeba keratitis.
    Li L; Sun X
    Med Hypotheses; 2008; 70(2):260-4. PubMed ID: 17689022
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.
    Kim BK; Hwang GB; Seu YB; Choi JS; Jin KS; Doh KO
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):1996-2001. PubMed ID: 26112463
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liposomal voriconazole (VOR) formulation for improved ocular delivery.
    de Sá FA; Taveira SF; Gelfuso GM; Lima EM; Gratieri T
    Colloids Surf B Biointerfaces; 2015 Sep; 133():331-8. PubMed ID: 26123854
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Value of nu/nu mice in the production of experimental amoebic keratitis with Acanthamoeba].
    Paniagua-Crespo E; Hasle DP; Humphery-Smith I; Bellon C; Simitzis AM
    C R Acad Sci III; 1989; 309(11):499-503. PubMed ID: 2516476
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine.
    Seal D; Hay J; Kirkness C; Morrell A; Booth A; Tullo A; Ridgway A; Armstrong M
    Eye (Lond); 1996; 10 ( Pt 4)():413-21. PubMed ID: 8944089
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization and pathogenetic role of proteinase from Acanthamoeba castellanii.
    Na BK; Kim JC; Song CY
    Microb Pathog; 2001 Jan; 30(1):39-48. PubMed ID: 11162184
    [TBL] [Abstract][Full Text] [Related]  

  • 71. In vitro effectiveness of povidone-iodine on Acanthamoeba isolates from human cornea.
    Gatti S; Cevini C; Bruno A; Penso G; Rama P; Scaglia M
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2232-4. PubMed ID: 9736540
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Purification and characterization of a 33 kDa serine protease from Acanthamoeba lugdunensis KA/E2 isolated from a Korean keratitis patient.
    Kim HK; Ha YR; Yu HS; Kong HH; Chung DI
    Korean J Parasitol; 2003 Dec; 41(4):189-96. PubMed ID: 14699259
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
    Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Controlled in vitro delivery of voriconazole and diclofenac to the cornea using contact lenses for the treatment of Acanthamoeba keratitis.
    Morgan SR; Pilia N; Hewitt M; Moses RL; Moseley R; Lewis PN; Morrison PWJ; Kelly SL; Parker JE; Whitaker D; Quantock AJ; Heard CM
    Int J Pharm; 2020 Apr; 579():119102. PubMed ID: 32007592
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acanthamoeba keratitis and contact lens disinfecting solutions.
    Tzanetou K; Miltsakakis D; Droutsas D; Alimisi S; Petropoulou D; Ganteris G; Dolapsaki E; Markomichelakis N; Mallias I; Malamou-Lada E
    Ophthalmologica; 2006; 220(4):238-41. PubMed ID: 16785754
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent advances in the treatment of Acanthamoeba keratitis.
    Kumar R; Lloyd D
    Clin Infect Dis; 2002 Aug; 35(4):434-41. PubMed ID: 12145728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The pathogenesis of Acanthamoeba keratitis.
    Niederkorn JY; Alizadeh H; Leher H; McCulley JP
    Microbes Infect; 1999 May; 1(6):437-43. PubMed ID: 10602676
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intracorneal instillation of latex beads induces macrophage-dependent protection against Acanthamoeba keratitis.
    Clarke DW; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4917-25. PubMed ID: 17065507
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
    Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
    Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of chlorhexidine disinfectant in vitro effect on environmental and ocular Acanthamoeba strains, the amoebic agents of human keratitis − an emerging sight-threatening corneal disease in Poland.
    Padzik M; Baltaza W; Szaflik JP; Hendiger E; Dybicz M; Chomicz L
    Ann Parasitol; 2018; 64(3):229-233. PubMed ID: 30316219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.